These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26635968)

  • 1. Tocilizumab is effective against polymyalgia rheumatica: experience in 13 intractable cases.
    Izumi K; Kuda H; Ushikubo M; Kuwana M; Takeuchi T; Oshima H
    RMD Open; 2015; 1(1):e000162. PubMed ID: 26635968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid-Sparing Effect of Tocilizumab and Methotrexate in Patients with Polymyalgia Rheumatica: A Retrospective Cohort Study.
    Izumi K; Murata O; Higashida-Konishi M; Kaneko Y; Oshima H; Takeuchi T
    J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34209126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of 2012 EULAR/ACR new classification criteria for polymyalgia rheumatica in Japanese patients diagnosed using Bird's criteria.
    Matsui K; Maruoka M; Yoshikawa T; Hashimoto N; Nogami M; Sekiguchi M; Azuma N; Kitano M; Tsunoda S; Sano H
    Int J Rheum Dis; 2018 Feb; 21(2):497-501. PubMed ID: 28264228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
    Devauchelle-Pensec V; Berthelot JM; Cornec D; Renaudineau Y; Marhadour T; Jousse-Joulin S; Querellou S; Garrigues F; De Bandt M; Gouillou M; Saraux A
    Ann Rheum Dis; 2016 Aug; 75(8):1506-10. PubMed ID: 26929219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances and challenges in the diagnosis and treatment of polymyalgia rheumatica.
    Kermani TA; Warrington KJ
    Ther Adv Musculoskelet Dis; 2014 Feb; 6(1):8-19. PubMed ID: 24489611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature.
    Macchioni P; Boiardi L; Catanoso M; Pulsatelli L; Pipitone N; Meliconi R; Salvarani C
    Semin Arthritis Rheum; 2013 Aug; 43(1):113-8. PubMed ID: 23433960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
    Dasgupta B; Cimmino MA; Kremers HM; Schmidt WA; Schirmer M; Salvarani C; Bachta A; Dejaco C; Duftner C; Jensen HS; Duhaut P; Poór G; Kaposi NP; Mandl P; Balint PV; Schmidt Z; Iagnocco A; Nannini C; Cantini F; Macchioni P; Pipitone N; Del Amo M; Espígol-Frigolé G; Cid MC; Martínez-Taboada VM; Nordborg E; Direskeneli H; Aydin SZ; Ahmed K; Hazleman B; Silverman B; Pease C; Wakefield RJ; Luqmani R; Abril A; Michet CJ; Marcus R; Gonter NJ; Maz M; Carter RE; Crowson CS; Matteson EL
    Arthritis Rheum; 2012 Apr; 64(4):943-54. PubMed ID: 22389040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in polymyalgia rheumatica.
    Owen CE; Buchanan RR; Hoi A
    Intern Med J; 2015 Nov; 45(11):1102-8. PubMed ID: 26036315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trial.
    Bolhuis TE; Marsman DE; den Broeder AA; den Broeder N; van der Maas A
    Lancet Rheumatol; 2023 Apr; 5(4):e208-e214. PubMed ID: 38251523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian variations in clinical symptoms and concentrations of inflammatory cytokines, melatonin, and cortisol in polymyalgia rheumatica before and during prednisolone treatment: a controlled, observational, clinical experimental study.
    Galbo H; Kall L
    Arthritis Res Ther; 2016 Jul; 18(1):174. PubMed ID: 27455959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy.
    Mori S; Koga Y
    Clin Rheumatol; 2016 May; 35(5):1367-75. PubMed ID: 24803231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.
    Gonzalez-Gay MA; Garcia-Porrua C; Salvarani C; Olivieri I; Hunder GG
    J Rheumatol; 2000 Sep; 27(9):2179-84. PubMed ID: 10990231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
    Dasgupta B; Cimmino MA; Maradit-Kremers H; Schmidt WA; Schirmer M; Salvarani C; Bachta A; Dejaco C; Duftner C; Jensen HS; Duhaut P; Poór G; Kaposi NP; Mandl P; Balint PV; Schmidt Z; Iagnocco A; Nannini C; Cantini F; Macchioni P; Pipitone N; Amo MD; Espígol-Frigolé G; Cid MC; Martínez-Taboada VM; Nordborg E; Direskeneli H; Aydin SZ; Ahmed K; Hazleman B; Silverman B; Pease C; Wakefield RJ; Luqmani R; Abril A; Michet CJ; Marcus R; Gonter NJ; Maz M; Carter RE; Crowson CS; Matteson EL
    Ann Rheum Dis; 2012 Apr; 71(4):484-92. PubMed ID: 22388996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial.
    Bonelli M; Radner H; Kerschbaumer A; Mrak D; Durechova M; Stieger J; Husic R; Mandl P; Smolen JS; Dejaco C; Aletaha D
    Ann Rheum Dis; 2022 Jun; 81(6):838-844. PubMed ID: 35210264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyalgia rheumatica: A case series from Colombia and analysis of Latin America.
    Toro-Gutiérrez CE; Cañas CA; Mantilla RD; Beltrán S; Pastrana-Gonzalez V; Vecino MJ; Rodriguez-Jimenez M; Rojas M
    J Transl Autoimmun; 2021; 4():100115. PubMed ID: 34485886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocilizumab in isolated polymyalgia rheumatica: A systematic literature review.
    Akiyama M; Kaneko Y; Takeuchi T
    Semin Arthritis Rheum; 2020 Jun; 50(3):521-525. PubMed ID: 32107035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swollen joints and peripheral arthritis are signs of malignancy in polymyalgia rheumatica.
    Michitsuji T; Iwanaga N; Horai Y; Tsuji Y; Kawahara C; Izumi Y; Taniguchi K; Yoshida S; Kawakami A
    Mod Rheumatol; 2019 Nov; 29(6):1013-1016. PubMed ID: 30334628
    [No Abstract]   [Full Text] [Related]  

  • 18. 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
    Dejaco C; Singh YP; Perel P; Hutchings A; Camellino D; Mackie S; Abril A; Bachta A; Balint P; Barraclough K; Bianconi L; Buttgereit F; Carsons S; Ching D; Cid M; Cimmino M; Diamantopoulos A; Docken W; Duftner C; Fashanu B; Gilbert K; Hildreth P; Hollywood J; Jayne D; Lima M; Maharaj A; Mallen C; Martinez-Taboada V; Maz M; Merry S; Miller J; Mori S; Neill L; Nordborg E; Nott J; Padbury H; Pease C; Salvarani C; Schirmer M; Schmidt W; Spiera R; Tronnier D; Wagner A; Whitlock M; Matteson EL; Dasgupta B; ;
    Ann Rheum Dis; 2015 Oct; 74(10):1799-807. PubMed ID: 26359488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polymyalgia rheumatica update, 2015].
    Schmidt Z; Poór G
    Orv Hetil; 2016 Jan; 157(1):2-12. PubMed ID: 26708681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyalgia rheumatica.
    Kermani TA; Warrington KJ
    Lancet; 2013 Jan; 381(9860):63-72. PubMed ID: 23051717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.